Randomized controlled trials of switching to a new medication versus continuing a chronic medication may underestimate risk of adverse events in those continuing because of asymmetric depletion of susceptibles
Source: Journal of Clinical Epidemiology - Category: Epidemiology Authors: Michael Colacci, Afsaneh Raissi, Prachi Ray, Michelle Sholzberg, Kenneth J. Rothman, Michael Fralick Tags: Letter to the Editor Source Type: research
More News: Epidemiology